CAS No.:1972-08-3

TOXICITY DATA with REFERENCE：

1.		dni-hmn:hla 40 µmol/L		ANTRD4    Anticancer Research. 3 (1983),211.
2.		oms-hmn:fbr 5 µmol/L		ANTRD4    Anticancer Research. 3 (1983),211.
3.		orl-mky TDLo:648 mg/kg (female 1-23W post):REP		NETOD7    Neurobehavioral Toxicology. 4 (1982),469.
4.		orl-mky TDLo:396 mg/kg (female 1-23W post):TER		AVBIB9    Advances in the Biosciences. 22/23 (1979),501.
5.		orl-rat LD50:666 mg/kg		PSEBAA    Proceedings of the Society for Experimental Biology and Medicine. 136 (1971),260.
6.		ipr-rat LD50:373 mg/kg		PSEBAA    Proceedings of the Society for Experimental Biology and Medicine. 136 (1971),260.
7.		ivn-rat LD50:29 mg/kg		ANYAA9    Annals of the New York Academy of Sciences. 191 (1971),74.
8.		orl-mus LD50:482 mg/kg		PSEBAA    Proceedings of the Society for Experimental Biology and Medicine. 136 (1971),260.
9.		ipr-mus LD50:168 mg/kg		AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 196 (1972),133.
10.		ivn-mus LD50:42 mg/kg		ANYAA9    Annals of the New York Academy of Sc

Consensus Reports：

EPA Genetic Toxicology Program.

SAFETY PROFILE：

Safety Information of 1-trans-delta-9-Tetrahydrocannabinol (CAS NO.1972-08-3):
Hazard Codes: F 
Risk Statements: 11
R11:Highly flammable
Safety Statements: 16-7
S16:Keep away from sources of ignition
S7:Keep container tightly closed
RIDADR: UN 1230 3/PG 2
WGK Germany: 1
HazardClass: 6.1(b)
PackingGroup: III
Poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion. Experimental reproductive effects. Questionable carcinogen with experimental tumorigenic and teratogenic data. Human mutation data reported. A hallucinatory drug. When heated to decomposition it emits acrid smoke and irritating fumes. See also CANNABIS.

Standards and Recommendations：

 

Analytical Methods：